Global Diagnostic Reagents Market, By Product Type (Chromatography Reagents, Molecular Diagnostic Reagents, Immunoassay Reagents, Clinical Chemistry Reagents, Flow Cytometry Reagents, Cell and Tissue Culture Reagents, Hematology and Hemostasis Reagents, Microbiology Reagents, Others) End User (Hospitals, Research Institutes, Laboratories, Biopharmaceutical Companies, Others) – Industry Trends and Forecast to 2030.
Diagnostic Reagents Market Analysis and Size
The market for diagnostic reagents is expected to grow during the forecast period of 2023 to 2030. Diagnostic reagents are lab chemicals to identify particular pathogens, metabolic irregularities, physiological anomalies, and hereditary illnesses. They are employed in vivo or in vitro to identify certain disorders and rely on medical professionals to make reliable diagnosis.
Data Bridge Market Research analyses that the diagnostic reagents market, valued at USD 48.90 billion in 2022, is expected to reach USD 84.01 billion by 2030, growing at a CAGR of 7.00% during the forecast period of 2023 to 2030. “Hospitals” dominates the end segment of the diagnostic reagents market owing to the higher in-house diagnostic testing comparatively to the others in the segment. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Diagnostic Reagents Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product Type (Sample Preparation Kits, Microarray Kits, PCR Assay Kits, In Situ Hybridization Kits, Sequencing Kits), End User (Hospitals, Research Institutes, Laboratories, Biopharmaceutical Companies, Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
Siemens (Germany),Hologic, Inc. (U.S.), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), Abbott (U.S.), BD (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Thermo Fisher Scientific Inc. (U.S.), Koninklijke Philips N.V. (Netherlands), NeuroLogica Corp.(U.S.), Shimadzu Medical (India) pvt. Ltd. (Japan), GENERAL ELECTRIC (U.S.), Quest Diagnostics Incorporated (U.S.), Sysmex India Pvt. Ltd. (Japan), Hitachi, Ltd. (Japan), Canon Inc. (Japan), FUJIFILM Holdings Corporation (U.K.)
|
|
Market Opportunities
|
|
Market Definition
A diagnostic reagent is any reagent used in vitro or in vivo to detect or screen a particular disease or any health-related issue. Any organic or inorganic substances that are added to an analyte or biological specimen, such as urine, blood, or biopsied human tissue, to identify aetiology or abnormalities are referred to as diagnostic reagents. Substances or compounds used in diagnostic testing to identify, detect, or measure specific biological or chemical substances in patient samples. These reagents are essential components of diagnostic tests and play a crucial role in disease diagnosis, monitoring, and treatment.
Global Diagnostic Reagents Market Dynamics
Drivers
- Increasing Prevalence of Chronic Diseases
The increasing prevalence of chronic diseases is a significant driver for the diagnostic reagents market. Chronic diseases, such as cardiovascular disorders, diabetes, and cancer, have become increasingly common worldwide. Diagnostic reagents play a crucial role in accurately identifying and monitoring these diseases. They are used in various diagnostic procedures, including blood tests, imaging techniques, and genetic testing, to detect biomarkers, specific molecules, or genetic variations associated with these diseases. By enabling early disease detection and monitoring, diagnostic reagents facilitate timely intervention, treatment planning, and disease management. With the rising burden of chronic diseases, the demand for diagnostic reagents continues to grow, driving market expansion.
- Technological Advancements in Diagnostics
Technological advancements in diagnostics have revolutionized the field of medicine and significantly impacted the demand for diagnostic reagents. Molecular diagnostics, immunoassays, and point-of-care testing are among the key technological innovations that have driven the market growth. Molecular diagnostics, including techniques like polymerase chain reaction (PCR) and next-generation sequencing (NGS), have enhanced the sensitivity and specificity of diagnostic tests. These advancements enable the detection of genetic variations, mutations, and infectious agents with high accuracy and precision. Immunoassays, such as enzyme-linked immunosorbent assays (ELISA), utilize specific antibodies to identify and quantify target molecules in patient samples. Point-of-care testing has also gained prominence due to its convenience and rapid results. These technological advancements have expanded the applications of diagnostic reagents, improved diagnostic accuracy, and accelerated testing workflows, leading to increased adoption of diagnostic reagents in healthcare settings.
- Growing Aging Population
The global aging population is a significant driver for the global diagnostic reagents market. As people age, the incidence of age-related diseases and conditions increases. Elderly individuals are more susceptible to chronic diseases, including cardiovascular disorders, neurodegenerative diseases, and certain types of cancer. Regular diagnostic testing becomes essential for disease detection, monitoring, and management in this population. Diagnostic reagents are critical in facilitating early disease detection, identifying disease progression, and monitoring treatment efficacy. They enable healthcare professionals to assess biomarkers, measure specific molecules, and detect genetic variations associated with age-related diseases. The growing aging population, coupled with the increasing focus on preventive healthcare, has led to a higher demand for diagnostic reagents to support geriatric care and improve patient outcomes.
Opportunities
- Emerging Markets
Developing economies present significant growth opportunities for the global diagnostic reagents market. The expanding healthcare infrastructure, increasing access to diagnostic services, and rising awareness about early disease detection in these regions are driving the demand for diagnostic reagents.
- High Prevalence and increase in the Incidence of Chronic Infectious Diseases
One of the most common uses of in vitro diagnostic reagents is the diagnosis of infectious and chronic disorders. Any diagnostic test requires the use of diagnostic reagents, including biological and chemical reagents. IVD reagents are essential in developing new diagnostic tools and tests for the early diagnosis and prevention of diseases, which have become more difficult due to the emergence and breakout of several infectious diseases.
Restraints
- Stringent Regulatory Frameworks
The global diagnostic reagents market faces challenges due to strict regulations imposed by regulatory authorities. The complex approval processes, stringent quality standards, and compliance requirements can hinder market growth and increase the time and cost of product development.
Challenges
- Supply Chain Disruptions
The global diagnostic reagents market is susceptible to supply chain disruptions, such as raw material shortages, transportation issues, and production delays. These disruptions can impact the availability and delivery of diagnostic reagents, leading to challenges in meeting the growing demand and potentially affecting patient care.
This global diagnostic reagents market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global diagnostic reagents market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In 2021, CYTENA launched C. LIVE Tox, reagents for real-time direct detection of cytotoxicity. C.LIVE Tox Green and Red are sensitive DNA-binding dyes that are nonpermeable to viable cells and nonfluorescent on the outside
- In March 2019, Ortho Clinical Diagnostics launched four new key assays to meet the demand of the rapidly rising diagnostics market in China. In order to address the need of the rapidly expanding diagnostics market, Ortho Clinical Diagnostics, a global pioneer in in vitro diagnostics, has launched four new critical assays. Cystatin C, -Hydroxybutyrate Dehydrogenase (HBDH), Homocysteine (HCY), and Total Bile Acid (TBA) are the assays that are added as part of this product launch, which was made possible by a partnership with Beijing Leadman Biochemistry Co., Ltd. of Beijing
Global Diagnostic Reagents Market Scope
The global diagnostic reagents market is segmented on the basis of product type and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product Type
- Chromatography Reagents
- Molecular Diagnostic Reagents
- Immunoassay Reagents
- Clinical Chemistry Reagents
- Flow Cytometry Reagents
- Cell and Tissue Culture Reagents
- Hematology and Hemostasis Reagents
- Microbiology Reagents
- Others
End-User
- Hospitals
- Research Institutes
- Laboratories
- Biopharmaceutical Companies
- Others
Diagnostic Reagents Market Regional Analysis/Insights
The diagnostic reagents market is analysed and market size insights and trends are provided by country, product type and end-user as referenced above.
The countries covered in the diagnostic reagents market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the global diagnostic reagents market due to the increasing use of molecular diagnostics in cancer screening and genetic disorders availability of government funds and the presence of major key players in the region.
Asia-Pacific is expected to grow at the highest growth rate in the global diagnostic reagents market in the forecast period of 2029 to 2030 due to the increase in popularity of molecular test over traditional tests such as microbiology test, surge in the incidence of lifestyle-related and chronic illnesses.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The diagnostic reagents market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for diagnostic reagents market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the diagnostic reagents market. The data is available for historic period 2015-2020.
Competitive Landscape and Diagnostic Reagents Market Share Analysis
The diagnostic reagents market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global diagnostic reagents market.
Some of the major players operating in the global diagnostic reagents market are:
- Siemens (Germany)
- Hologic, Inc. (U.S.)
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)
- Abbott (U.S.)
- BD (U.S.)
- F. Hoffmann-La Roche Ltd (Switzerland)
- Thermo Fisher Scientific Inc. (U.S.)
- Koninklijke Philips N.V. (Netherlands)
- NeuroLogica Corp.(U.S.)
- Shimadzu Medical (India) pvt. Ltd. (Japan)
- GENERAL ELECTRIC (U.S.)
- Quest Diagnostics Incorporated (U.S.)
- Sysmex India Pvt. Ltd. (Japan)
- Hitachi, Ltd. (Japan)
- Canon Inc. (Japan)
- FUJIFILM Holdings Corporation (U.K.)
SKU-